10.02.2013 Views

Immunotherapy for Infectious Diseases

Immunotherapy for Infectious Diseases

Immunotherapy for Infectious Diseases

SHOW MORE
SHOW LESS

Create successful ePaper yourself

Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.

260 Sili, Heslop, and Rooney<br />

Fig. 1. Generation of cell-mediated immune response. For activation of naive T-helper (Th)<br />

and cytotoxic T-lymphocytes (CTLs), professional antigen-presenting cells (e.g., dendritic cells<br />

[DCs]) are required. DCs process the antigens and present the immunogenic peptides in an<br />

MHC context with simultaneous delivery of costimulatory signals (e.g., B7/CD28 or<br />

CD40/CD40 ligand signals) to activate T-lymphocytes. Two antigen-processing pathways are<br />

generally accepted. In the cytosolic pathway, endogenously synthesized antigens (cytoplasmic<br />

proteins) are digested in proteosomes and transported into the endoplasmic reticulum (ER) by<br />

transporters associated with antigen processing (TAPs), where they complex with MHC class I<br />

molecules <strong>for</strong> presentation to CD8� CTLs. In the endosomal pathway, extracellular antigens<br />

are phagocytozed, digested in lysosomes, and then complexed with MHC class II molecules in<br />

vesicles <strong>for</strong> presentation to CD4� Th-lymphocytes. See the text <strong>for</strong> more details.<br />

become the targets of cellular immune responses, usually resulting in eradication of the<br />

infected cell by CTLs. Professional antigen-presenting cells (i.e., dendritic cells [DCs]<br />

or macrophages) and T-helper lymphocytes orchestrate the CTL response (Fig. 1).<br />

Virus-specific CD4� T-helper (Th) lymphocytes and CD8� CTLs generally mediate<br />

the effector mechanisms necessary and sufficient to resolve acute infection as well<br />

as provide recall immune responses to resist reexposure to acute viruses and to control<br />

the reactivation of latent viruses. Viruses have diverse mechanisms to evade immune<br />

responses (3), although in most cases the immune system prevails and controls the<br />

infection.<br />

CD8� CTLs recognize virus-infected cells through interaction of their T-cell receptor<br />

with peptides bound to the major histocompatibility complex (MHC) class I molecule<br />

of the infected cell. Endogenously synthesized proteins of the virus are degraded<br />

into short peptides by the antigen-processing machinery and presented in the MHC<br />

class I context (4). Peptides are generally 8–10 amino acids long, are generated within<br />

cells by a cytoplasmic proteolytic complex known as the proteosome, and are then<br />

transported into the endoplasmic reticulum by transporters associated with antigen processing<br />

(TAPs), where they are complexed with MHC class I molecules <strong>for</strong> cell surface<br />

presentation (5). Virtually all nucleated cells are MHC class I-positive and thus

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!